Artigo de periodico

Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors) (2023)

• Authors:
  • Bonifácio, Lívia Pimenta
  • Ramacciotti, Eduardo
  • Agati, Leandro Barile
  • Vilar, Fernando Crivelenti
  • Silva, Anna Christina Tojal da
  • Louzada Junior, Paulo
  • Fonseca, Benedito Antonio Lopes da
  • Souza, Hayala Cristina Cavenague de
  • Oliveira, Caroline Candida Carvalho de
  • Aguiar, Valeria Cristina Resende
  • Kallas, Esper Georges
  • Rodrigues, Fernando Bellíssimo
• USP affiliated authors: RODRIGUES, FERNANDO BELLISSIMO - FMRP ; KALLAS, ESPER GEORGES - FM ; LOUZADA JÚNIOR, PAULO - FMRP ; FONSECA, BENEDITO ANTONIO LOPES DA - FMRP
• Unidades: FMRP; FM
• DOI: 10.1590/0037-8682-0565-2022
• Subjects: COVID-19; PACIENTES INTERNADOS; PANDEMIAS; BRASIL
• Agências de fomento:
  • Financiamento CNPq
  • Financiamento MCTI
• Language: Inglês
• Imprenta:
  • Publisher place: Brasilia
  • Date published: 2023
• Source:
  • Título: Revista da sociedade brasileira de medicina tropical
  • ISSN: 0037-8682
  • Volume/Número/Paginação/Ano: v. 56, article ID e0565-2022, 10p, 2023

Informações sobre o DOI: 10.1590/0037-8682-0565-2022 (Fonte: oaDOI API)
• Este periódico é de acesso aberto
• Este artigo NÃO é de acesso aberto
  

---

Download do texto completo

Tipo	Nome	Link
	003191554.pdf

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  BONIFÁCIO, Lívia Pimenta et al. Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors). Revista da sociedade brasileira de medicina tropical, v. 56, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54695. Acesso em: 17 fev. 2026.

• APA

  Bonifácio, L. P., Ramacciotti, E., Agati, L. B., Vilar, F. C., Silva, A. C. T. da, Louzada Junior, P., et al. (2023). Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors). Revista da sociedade brasileira de medicina tropical, 56. doi:10.1590/0037-8682-0565-2022

• NLM

  Bonifácio LP, Ramacciotti E, Agati LB, Vilar FC, Silva ACT da, Louzada Junior P, Fonseca BAL da, Souza HCC de, Oliveira CCC de, Aguiar VCR, Kallas EG, Rodrigues FB. Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors) [Internet]. Revista da sociedade brasileira de medicina tropical. 2023 ; 56[citado 2026 fev. 17 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54695

• Vancouver

  Bonifácio LP, Ramacciotti E, Agati LB, Vilar FC, Silva ACT da, Louzada Junior P, Fonseca BAL da, Souza HCC de, Oliveira CCC de, Aguiar VCR, Kallas EG, Rodrigues FB. Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors) [Internet]. Revista da sociedade brasileira de medicina tropical. 2023 ; 56[citado 2026 fev. 17 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54695

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors)
• Bacillary angiomatosis in a pregnant woman
• Manifestação extrapulmonar da tuberculose apresentando-se como pseudotumor orbitário
• No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure Prophylaxis
• Subsets of Memory CD4+ T Cell and Bactericidal Antibody Response to Neisseria meningitidis Serogroup C after Immunization of HIV-Infected Children and Adolescents
• Viral infections and implications for male reproductive health
• Global Assessment of Dengue Virus-Specific CD4+ T Cell Responses in Dengue-Endemic Areas
• Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance
• Antigenic competition in CD4(+) T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial
• Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository